Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BIOR

Biora Therapeutics (BIOR)

Biora Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOR
DateTimeSourceHeadlineSymbolCompany
05/20/20243:08PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BIORBiora Therapeutics Inc
05/20/20243:06PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BIORBiora Therapeutics Inc
05/20/20247:00AMGlobeNewswire Inc.Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024NASDAQ:BIORBiora Therapeutics Inc
05/15/20243:05PMGlobeNewswire Inc.Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:BIORBiora Therapeutics Inc
05/07/20247:00AMGlobeNewswire Inc.Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:BIORBiora Therapeutics Inc
05/06/20247:00AMGlobeNewswire Inc.Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024NASDAQ:BIORBiora Therapeutics Inc
04/30/20247:00AMGlobeNewswire Inc.Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600NASDAQ:BIORBiora Therapeutics Inc
04/08/20247:00AMGlobeNewswire Inc.Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery TechnologyNASDAQ:BIORBiora Therapeutics Inc
04/04/20247:00AMGlobeNewswire Inc.Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform DevelopmentNASDAQ:BIORBiora Therapeutics Inc
04/03/20243:05PMGlobeNewswire Inc.Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BIORBiora Therapeutics Inc
04/01/20247:00AMGlobeNewswire Inc.Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BIORBiora Therapeutics Inc
03/26/20243:05PMGlobeNewswire Inc.Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:BIORBiora Therapeutics Inc
03/26/20246:21AMIH Market NewsU.S. Index Futures on the Rise, Oil Prices Show StabilityNASDAQ:BIORBiora Therapeutics Inc
03/18/20247:00AMGlobeNewswire Inc.Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate UpdateNASDAQ:BIORBiora Therapeutics Inc
03/11/20247:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
03/11/20247:00AMGlobeNewswire Inc.Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy AssetNASDAQ:BIORBiora Therapeutics Inc
02/26/20247:00AMGlobeNewswire Inc.Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600NASDAQ:BIORBiora Therapeutics Inc
02/15/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIORBiora Therapeutics Inc
02/15/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIORBiora Therapeutics Inc
02/14/20241:43PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIORBiora Therapeutics Inc
02/08/20247:00AMGlobeNewswire Inc.Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease SymposiumNASDAQ:BIORBiora Therapeutics Inc
01/22/20247:00AMGlobeNewswire Inc.Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.NASDAQ:BIORBiora Therapeutics Inc
01/16/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIORBiora Therapeutics Inc
01/16/20247:00AMGlobeNewswire Inc.Biora Therapeutics Provides Outlook for 2024NASDAQ:BIORBiora Therapeutics Inc
01/08/20247:00AMGlobeNewswire Inc.Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600NASDAQ:BIORBiora Therapeutics Inc
01/02/20247:00AMGlobeNewswire Inc.Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery PlatformNASDAQ:BIORBiora Therapeutics Inc
01/01/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIORBiora Therapeutics Inc
12/22/20234:19PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BIORBiora Therapeutics Inc
12/20/20233:35PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BIORBiora Therapeutics Inc
12/19/20237:00AMGlobeNewswire Inc.Biora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery PlatformNASDAQ:BIORBiora Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BIOR

Your Recent History

Delayed Upgrade Clock